Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2098191-53-6
2. Eft226
3. Eft-226
4. Zotatifin [inn]
5. Zotatifin [usan]
6. 2ewn8z05cn
7. 4-((5ar,6s,7s,8r,8as)-7-((dimethylamino)methyl)-8,8a-dihydroxy-1,3-dimethoxy-6-phenyl-6,7,8,8a-tetrahydro-5ah-cyclopenta[4,5]furo[3,2-c]pyridin-5a-yl)benzonitrile
8. 4-((5ar,6s,7s,8r,8as)-7-((dimethylamino)methyl)-8,8a-dihydroxy-1,3-dimethoxy-6-phenyl-6,7,8,8a-tetrahydro-5ah-cyclopenta(4,5)furo(3,2-c)pyridin-5a-yl)benzonitrile
9. Benzonitrile, 4-((5ar,6s,7s,8r,8as)-7-((dimethylamino)methyl)-6,7,8,8a-tetrahydro-8,8a-dihydroxy-1,3-dimethoxy-6-phenyl-5ah-cyclopenta(4,5)furo(3,2-c)pyridin-5a-yl)-
10. Zotafin
11. Rel-zotatifin
12. Zotatifin (usan/inn)
13. Unii-2ewn8z05cn
14. Zotatifin [who-dd]
15. Chembl4303782
16. Schembl18864788
17. Dtxsid001022536
18. Ex-a4623
19. Bdbm50540861
20. Nsc818001
21. Nsc828584
22. Who 10998
23. Nsc-818001
24. Nsc-828584
25. Hy-112163
26. Cs-0043584
27. D11837
28. A937238
29. 4-[(2s,3r,4s,5s,6r)-4-[(dimethylamino)methyl]-2,3-dihydroxy-10,12-dimethoxy-5-phenyl-7-oxa-11-azatricyclo[6.4.0.02,6]dodeca-1(12),8,10-trien-6-yl]benzonitrile
Molecular Weight | 487.5 g/mol |
---|---|
Molecular Formula | C28H29N3O5 |
XLogP3 | 2.4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 6 |
Exact Mass | 487.21072103 g/mol |
Monoisotopic Mass | 487.21072103 g/mol |
Topological Polar Surface Area | 108 Ų |
Heavy Atom Count | 36 |
Formal Charge | 0 |
Complexity | 819 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
37
PharmaCompass offers a list of Zotatifin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Zotatifin manufacturer or Zotatifin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Zotatifin manufacturer or Zotatifin supplier.
PharmaCompass also assists you with knowing the Zotatifin API Price utilized in the formulation of products. Zotatifin API Price is not always fixed or binding as the Zotatifin Price is obtained through a variety of data sources. The Zotatifin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Zotatifin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zotatifin, including repackagers and relabelers. The FDA regulates Zotatifin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zotatifin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Zotatifin supplier is an individual or a company that provides Zotatifin active pharmaceutical ingredient (API) or Zotatifin finished formulations upon request. The Zotatifin suppliers may include Zotatifin API manufacturers, exporters, distributors and traders.
Zotatifin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Zotatifin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zotatifin GMP manufacturer or Zotatifin GMP API supplier for your needs.
A Zotatifin CoA (Certificate of Analysis) is a formal document that attests to Zotatifin's compliance with Zotatifin specifications and serves as a tool for batch-level quality control.
Zotatifin CoA mostly includes findings from lab analyses of a specific batch. For each Zotatifin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Zotatifin may be tested according to a variety of international standards, such as European Pharmacopoeia (Zotatifin EP), Zotatifin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zotatifin USP).